“I am extremely honored and excited to have the opportunity to serve as an Advisor to Sproxil, a company that has combined cutting edge technology and very creative approaches to tackle a range of difficult brand protection challenges,” said Chris Israel. “I've been inspired and impressed by Sproxil's leadership, and I look forward to lending my expertise and experience to their efforts.”
Sproxil's Mobile Product Authentication™ (MPA™) solution allows consumers to verify that the product they are buying is genuine by using a mobile phone and a simple, free text message. Using a scratch card method, similar to that used for replenishing cellular talk-time, the company allows users to reveal a one-time-use code on drugs and text the code to a “911 for fake drugs” number which is identical on all cellular networks within a country. The solution has been shown to be the most secure and reliable available on the market. Both local companies and global pharmaceutical companies, including GSK and Johnson & Johnson, are using MPA to meet their brand protection needs.
Israel served as the first Presidentially-appointed U.S. Coordinator for International Intellectual Property Enforcement from 2005-2008, where his responsibilities included coordinating and leveraging the resources of the U.S. government to protect American intellectual property at home and abroad. He was frequently called upon to testify before Congress and represent the United States internationally on a range of issues that impacted American intellectual property rights holders. He was named one of the 50 “Most Influential People on IP” by Managing Intellectual Property magazine in 2006.
“Sproxil offers solutions that matter profoundly to emerging markets plagued by counterfeit products that threaten the health and safety of consumers, and give rise to an illicit economy that stifles innovation and economic opportunity,” said Dr. Ashifi Gogo, CEO of Sproxil. “The addition of such a renowned, well connected international trade expert like Chris Israel to our Board of Advisors aids our mission to influence public policy efforts to improve the lives of individuals throughout the world by ensuring access to the genuine medicines they need - generic and branded drugs alike.”
Earlier in his career, Israel worked as a public policy executive for Time Warner and as a staffer on Capitol Hill. He received a Bachelor of Science degree from the University of Kansas and an M.B.A. from The George Washington University.
The other members of the advisory board are Egbe Osifo-Dawodu, MD, partner at Anadach Group, formerly with the World Bank Institute; Ethan Zuckerman, serial entrepreneur and senior researcher at the Berkman Center for Internet and Society at Harvard University; Mitual Shah, director of engineering at the West Wireless Institute; and Paul W Chang, Global Business Strategy Lead, Emerging Technologies for IBM Software Group.